Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2003 Jun 10:3:2.
doi: 10.1186/1472-6882-3-2. Epub 2003 Jun 10.

Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report

Affiliations
Case Reports

Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report

Wim J van Blitterswijk et al. BMC Complement Altern Med. .

Abstract

Background: Glucosamine and chondroitin sulfate preparations are widely used as food supplements against osteoarthritis, but critics are skeptical about their efficacy, because of the lack of convincing clinical trials and a reasonable scientific rationale for the use of these nutraceuticals. Most trials were on osteoarthritis of the knee, while virtually no documentation exists on spinal disc degeneration. The purpose of this article is to highlight the potential of these food additives against cartilage degeneration in general, and against symptomatic spinal disc degeneration in particular, as is illustrated by a case report. The water content of the intervertebral disc is a reliable measure of its degeneration/ regeneration status, and can be objectively determined by Magnetic Resonance Imaging (MRI) signals.

Case presentation: Oral intake of glucosamine and chondroitin sulfate for two years associated with disk recovery (brightening of MRI signal) in a case of symptomatic spinal disc degeneration. We provide a biochemical explanation for the possible efficacy of these nutraceuticals. They are bioavailable to cartilage chondrocytes, may stimulate the biosynthesis and inhibit the breakdown of their extracellular matrix proteoglycans.

Conclusion: The case suggests that long-term glucosamine and chondroitin sulfate intake may counteract symptomatic spinal disc degeneration, particularly at an early stage. However, definite proof requires well-conducted clinical trials with these food supplements, in which disc de-/regeneration can be objectively determined by MRI. A number of biochemical reasons (that mechanistically need to be further resolved) explain why these agents may have cartilage structure- and symptom-modifying effects, suggesting their therapeutic efficacy against osteoarthritis in general.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Disc cartilage regeneration during 2 years of supplement intake. T2-weighted MR images of lumbar spine, made in September 1999 (start of supplement intake), 2000 and 2001. Note the increase of MRI signal of disc L3-4 (thick arrows) and disappearance of focal disc protrusion (thin arrow) of this disc. Note that the fully degenerated L4-5 disc remains unchanged. Upper panels and lower panels represent two consecutive images of planes 4 mm apart.

Similar articles

Cited by

References

    1. Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, Aebi M, Alini M. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 1996;98:996–1003. - PMC - PubMed
    1. Cole TC, Ghosh P, Taylor TK. Variations of the proteoglycans of the canine intervertebral disc with ageing. Biochim Biophys Acta. 1986;880:209–219. doi: 10.1016/0304-4165(86)90082-6. - DOI - PubMed
    1. Coventry MB, Ghormley RL, Kernohan JW. The intervertebral disc: its microscopic anatomy and pathology. I. Anatomy, development and pathology. J Bone Joint Surg Am. 1945;27:105–112.
    1. Coventry MB, Ghormley RL, Kernohan JW. The intervertebral disc: its microscopic anatomy and pathology. II. Changes in the intervertebral disc concomittant with age. J Bone Joint Surg Am. 1945;27:233–247.
    1. Coventry MB, Ghormley RL, Kernohan JW. The intervertebral disc: its microscopic anatomy and pathology. III. Pathologic changes in the intervertebral disc. J Bone Joint Surg Am. 1945;27:460–474.

Publication types

MeSH terms